These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7526647)
1. Increased numbers of circulating basophils with decreased releasability after administration of rhG-CSF to allergic patients. Pedersen M; Kristensen KS; Clementsen P; Olsen OT; Skov PS; Permin H; Norn S Agents Actions; 1994 Jun; 41 Spec No():C24-5. PubMed ID: 7526647 [TBL] [Abstract][Full Text] [Related]
2. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Casolaro V; Spadaro G; Marone G Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653 [TBL] [Abstract][Full Text] [Related]
3. The in vivo and in vitro effects of rhG-CSF on allergic, haematological and biochemical variables. Kristensen KS; Pedersen M; Clementsen P; Olsen OT; Skov PS; Permin H; Norn S APMIS; 1998 Nov; 106(11):1108-12. PubMed ID: 9890275 [TBL] [Abstract][Full Text] [Related]
4. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Winther L; Moseholm L; Reimert CM; Stahl Skov P; Kaergaard Poulsen L Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774 [TBL] [Abstract][Full Text] [Related]
5. Enhanced basophil histamine release to concanavalin A in allergic rhinitis. Busse WW; Swenson CA; Sharpe G; Koschat M J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):90-7. PubMed ID: 2424961 [TBL] [Abstract][Full Text] [Related]
6. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127 [TBL] [Abstract][Full Text] [Related]
7. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. de Paulis A; Valentini G; Spadaro G; Lupoli S; Tirri G; Marone G Arthritis Rheum; 1991 Oct; 34(10):1289-96. PubMed ID: 1718285 [TBL] [Abstract][Full Text] [Related]
9. Human basophil releasability. III. Genetic control of human basophil releasability. Marone G; Poto S; Celestino D; Bonini S J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036 [TBL] [Abstract][Full Text] [Related]
10. Study of IgE-dependent basophil releasability in allergic patients. Sanz ML; Latasa M; García BE; Gato JJ; Oehling A J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011 [TBL] [Abstract][Full Text] [Related]
11. Measurement of histamine-releasing factor activity in individual nasal washings: relationship with atopy, basophil response, and membrane-bound IgE. Sim TC; Alam R; Forsythe PA; Welter JB; Lett-Brown MA; Grant JA J Allergy Clin Immunol; 1992 Jun; 89(6):1157-65. PubMed ID: 1376736 [TBL] [Abstract][Full Text] [Related]
12. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Linden M; Svensson C; Andersson M; Greiff L; Andersson E; Denburg JA; Persson CG Allergy; 1999 Mar; 54(3):212-9. PubMed ID: 10321556 [TBL] [Abstract][Full Text] [Related]
13. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma. Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469 [TBL] [Abstract][Full Text] [Related]
14. Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy. Korošec P; Šilar M; Kopač P; Eržen R; Zidarn M; Košnik M Int Arch Allergy Immunol; 2016; 171(2):89-101. PubMed ID: 27907922 [TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. Casolaro V; Spadaro G; Patella V; Marone G J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. Sperr WR; Agis H; Semper H; Valenta R; Susani M; Sperr M; Willheim M; Scheiner O; Liehl E; Lechner K; Valent P Int Arch Allergy Immunol; 1997 Sep; 114(1):68-73. PubMed ID: 9303333 [TBL] [Abstract][Full Text] [Related]
17. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. Sabroe RA; Francis DM; Barr RM; Black AK; Greaves MW J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):651-8. PubMed ID: 9802375 [TBL] [Abstract][Full Text] [Related]
18. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Gaddy JN; Busse WW Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179 [TBL] [Abstract][Full Text] [Related]
19. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. Sarmiento EU; Espiritu BR; Gleich GJ; Thomas LL J Immunol; 1995 Aug; 155(4):2211-21. PubMed ID: 7543541 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]